We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reduction of Abdominal Obesity and Insulin Resistance in Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00664495
Recruitment Status : Completed
First Posted : April 23, 2008
Last Update Posted : April 23, 2008
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
The purpose of the study was to assess the effects of equivalent diet- or exercise-induced weight loss and related insulin resistance in abdominally obese women.

Condition or disease Intervention/treatment
Obesity Behavioral: Diet Weight Loss Behavioral: Exercise Weight Loss Behavioral: Exercise Without Weight Loss

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Official Title: Reduction of Abdominal Obesity and Insulin Resistance in Women
Study Start Date : April 1999
Primary Completion Date : December 2003
Study Completion Date : December 2003

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
No Intervention: C
Control
Active Comparator: DWL
Diet Weight Loss
Behavioral: Diet Weight Loss
Active Comparator: EWL
Exercise Weight Loss
Behavioral: Exercise Weight Loss
Active Comparator: EWS
Exercise Without Weight Loss
Behavioral: Exercise Without Weight Loss


Outcome Measures

Primary Outcome Measures :
  1. Abdominal Obesity [ Time Frame: 4 months ]
  2. Insulin Resistance [ Time Frame: 4 Months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Premenopausal women

Exclusion Criteria:

  • Smokers and diabetics
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00664495


Locations
Canada, Ontario
Queen's University
Kingston, Ontario, Canada, K7L 3N6
Sponsors and Collaborators
Queen's University
Canadian Institutes of Health Research (CIHR)
Investigators
Principal Investigator: Robert Ross, PhD Queen's University
More Information

Publications:
Responsible Party: Queen's University
ClinicalTrials.gov Identifier: NCT00664495     History of Changes
Other Study ID Numbers: Ross 1999
First Posted: April 23, 2008    Key Record Dates
Last Update Posted: April 23, 2008
Last Verified: April 2008

Keywords provided by Queen's University:
Obesity, exercise, diet, insulin resistance

Additional relevant MeSH terms:
Obesity
Insulin Resistance
Obesity, Abdominal
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Insulin
Hypoglycemic Agents
Physiological Effects of Drugs